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Abstract
Background: reduced telomere length in blood cells has been associated with increased risk of multiple age-related diseases
and is widely regarded as a general biomarker of ageing. Therefore, it is important to know both the extent and limitations
of this association. We investigated the relation between telomere length and anaemia in two independent cohorts, with the
prior expectation of adding anaemia to the list of conditions for which telomere reduction is a risk factor.
Participants and methods: the present study is embedded in the Newcastle 85-plus Study and Leiden 85-plus Study, two
population-based studies of inhabitants of Newcastle and North Tyneside, UK (n = 749) and Leiden, the Netherlands
(n = 658) aged 85 and over. High-molecular-weight DNA was isolated from full fresh blood (Newcastle) and peripheral blood
mononuclear cells samples (Leiden). Telomere length was measured as abundance of telomeric template versus a single gene
by quantitative real-time polymerase chain reaction. Anaemia was defined according to World Health Organization criteria.
Results: in both studies, no differences in median telomere length were observed between participants with anaemia and par-
ticipants without anaemia (Newcastle: 2,846 bp (interquartile range (IQR) 2,433–3,630) versus 2,920 bp (IQR 2,425–3,570),
P = 0.63; Leiden: 4,136 bp (IQR 3,879–4,428) versus 4,167 bp (IQR 3,893–4,501), P = 0.41). Telomere length also did not
correlate with any other haematological parameter in both men and women.
Conclusions: in contrast to other age-related diseases, telomere length is not associated with anaemia or any other haematolo-
gical parameter in older individuals in the general population.
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Reduced telomere length in blood cells has been associated
with increased risk of multiple age-related diseases, such as
dementia [1], myocardial infarction [2], heart failure [3],
atherosclerosis [4] and solid tissue tumours [5] and is widely
regarded as a general biomarker of aging [6]. Therefore, it is
important to know both the extent and limitations of this
association. In the present study, we investigated the
relation between telomere length and anaemia, another
highly common condition in older individuals [7], in two
population-based studies of individuals aged 85 years and
over, with the prior expectation of adding anaemia to the
list of conditions for which telomere reduction is a risk
factor.
Method
Study populations and procedures
Newcastle 85-plus Study
The Newcastle 85-plus Study is a population-based study
of 85-year-old inhabitants of Newcastle and North
Tyneside, UK. The study protocol and baseline findings
have been described in detail elsewhere [8, 9]. In short, all
individuals who turned 85 during the year 2006 (i.e. born
in 1921) and who were registered with any Newcastle or
North Tyneside Primary Care Trust general practice were
eligible for study participation (n= 1,453). Of the 1,042
persons that agreed to participate (response rate 71.7%),
778 participants agreed to blood sampling. For the present
analyses, data from 749 participants with complete haemo-
globin and telomere data were included.
From every participant informed consent was obtained.
If the individual was not able to give informed consent due
to cognitive impairment, assent was sought from a care-
giver, according to the UK Mental Capacity Act 2005. The
study was approved by the Newcastle & North Tyneside
Local Research Ethics Committee.
At baseline, all information was obtained during three
home visits at the participant’s place of residence. During
these visits, several questionnaires on socio-economic status
(income, level of education) and lifestyle were completed,
and a number of measurements and function tests were
performed (e.g. Mini Mental State Examination [10]). One
additional visit was made to collect fasting blood samples.
The participants’ general practitioner records were reviewed
to obtain information about medical history.
The Leiden 85-plus Study
The Leiden 85-plus Study is a population-based prospective
study of inhabitants of Leiden, the Netherlands, aged 85
years and over. For the present analyses, we made use of
the first cohort enrolled between December 1986 and
March 1988. A detailed description of the study procedures
can be found elsewhere [11]. In short, on 1 December
1986, the community of Leiden in the Netherlands had
105,000 inhabitants, of whom 1,258 (1%) were 85 years
and over. During the enrolment period from 1 December
1986 to 1 March 1988, 221 participants died before they
could be visited. Of the remaining 1,037 people who were
eligible for the study, 977 (94%) agreed to participate.
Blood was taken from 905 subjects. The present study
includes data from 658 participants for whom complete
data on telomere length and haematological parameters
were available.
The Medical Ethical Committee of the Leiden
University Medical Centre approved the study, and
informed consent was obtained from all subjects or their
guardian for cognitively impaired subjects. During two
home visits, participants were interviewed and blood
samples were taken according to predefined protocols
under non-fasting conditions. The medical history was
obtained from the participants and in memory-impaired
subjects from partners and carers.
Main laboratory measurements
Routine haematology was performed on anti-coagulated
whole blood samples (ethylenediaminetetraacetic acid
(EDTA)-coated tubes) using standard automated analysis
systems. Anaemia was defined according to World Health
Organization criteria (haemoglobin (Hb) <12 g/dl for
women and Hb <13 g/dl for men) [12].
In the Newcastle 85-plus Study, DNA was extracted
from full fresh blood (white blood cells, i.e. granulocytes
and peripheral blood mononuclear cells (PBMC)) with the
QiaAmp DNA Maxi kit (Qiagen Ltd, Crawley, UK). In the
Leiden 85-plus Study, DNA was extracted from PBMC
samples stored at −80°C using the QiaAmp DNA Mini kit
(Qiagen Ltd, Crawley, UK).
DNA concentration and quality were monitored by
agarose gel electrophoresis. Samples were discarded if
DNA degradation (smear <20 kb) was visible. Telomere
length was measured as the ratio of the starting quantity for
telomeres versus the starting quantity for the single copy
gene of glyceraldehyde-3-phosphate dehydrogenase (as
control) by quantitative real-time polymerase chain reaction
(PCR) [13] with modifications as described previously [14].
Measurements were performed in quadruplicates. Three
DNA samples with known telomere lengths (3.0, 5.5 and
9.5 kb pairs) were run as internal standards together with
each batch of 16 study samples to convert the ratios of
starting quality into telomere lengths in base pairs. The
intra-assay coefficient of variation for this PCR method in
our lab is 2.65% and the inter-assay coefficient of variation
is 5.12%.
Additional laboratory measurements
Additional laboratory measurements were performed in the
Newcastle 85-plus Study. Ferritin levels were determined by
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ADVIA Centaur chemiluminescence immunoassay in
serum samples. A chemiluminescence microparticle immu-
noassay on an Abbott ARCHITECT analyser was used to
determine vitamin B12 in plasma and red cell folate levels
from EDTA anti-coagulated blood samples. Serum creati-
nine levels were measured as a proxy of renal function on
an Olympus AU640 system. Serum high-sensitivity
C-reactive protein (CRP) levels were determined as an indi-
cator of inflammatory status by the Dade Behring
CardioPhase hsCRP immunoassay.
Data analysis
In both studies, differences in telomere length between par-
ticipants with and without anaemia were tested with Mann–
Whitney U tests. The relation between telomere length and
haemoglobin levels was displayed in scatter plots with
superimposed regression lines, stratified by gender and ana-
lysed with linear regression analysis. Differences in haema-
tological characteristics between quintiles of telomere length
were tested with χ2 tests (categorical data) or Jonkheere–
Terpstra tests (continuous data), for men and women
separately.
In the Newcastle 85-plus Study, telomere length was
also compared between participants with red blood cell
count (RBC), platelets and white blood cell count
(WBC) in the lowest (gender-dependent) quartile and
participants with RBC, platelets and WBC in the highest
(gender-dependent) quartile. In addition, we used Mann–
Whitney U tests to analyse differences in telomere length
between participants with explained and unexplained
anaemia. Explained anaemia was defined as the presence
of anaemia and one or more of the following: ferritin
concentration <15 μg/l, vitamin B12 concentration
<170 pg/ml, red cell folate concentration <160 μg/l,
CRP concentration >5 mg/l and/or creatinine concen-
tration >155 μmol/l. In the Newcastle 85-plus study,
unexplained anaemia was defined as the presence of
anaemia with normal ferritin, vitamin B12, red cell folate,
CRP and creatinine concentrations. Furthermore, we
compared telomere length between participants with
unexplained anaemia and participants without anaemia
and normal ferritin, vitamin B12, red cell folate, CRP
and creatinine concentrations.
Data analyses were performed using SPSS 16.0 for
Windows (SPSS Inc., Chicago, IL. USA).
Results
Table 1 describes the socio-demographic and haematologi-
cal characteristics of both study populations. All partici-
pants in the Newcastle 85-plus Study were aged 85 years.
The median age of the cohort from Leiden was 89 years
(interquartile range (IQR) 88–92). Compared with partici-
pants in the Newcastle 85-plus Study, the prevalence of
institutionalisation and smoking was higher among
participants in the Leiden 85-plus Study. The prevalence of
stroke, myocardial infarction and malignancy was lower in
the Leiden 85-plus Study (Table 1).
The prevalence of anaemia was 29.6% (n= 222/749) in
the Newcastle 85-plus Study and 19.3% (n= 127/658) in
the Leiden 85-plus Study. In the Newcastle 85-plus Study,
the prevalence of anaemia in men was 33.2% (98/295) and
27.3% in women (124/454), χ2 test P = 0.08. In the Leiden
85-plus Study, the prevalence of anaemia was higher in
men than in women: men 26.7% (47/176) versus women
16.6% (80/482), P < 0.01). Participants in the Newcastle
85-plus Study had shorter telomeres than participants
in the Leiden 85-plus Study. In both studies, women
had shorter telomeres than men (Mann–Whitney U test
P< 0.01).
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 1. Socio-demographic, haematological and clinical






Age 85 89 (88–92)
Men 295 (39.4%) 176 (26.7%)
Institutionalisation 62 (8.3%) 354 (53.8%)
Current smoking 42 (5.6%) 102 (15.5%)
Haematological
characteristics
Haemoglobin (g/dl) 13.1 (12.1–14.1) 13.4 (12.3–14.2)
Haematocrit (%) 0.40 (0.37–0.43) 0.41 (0.38–0.43)
MCV (fl) 94 (90–97) 91 (88–94)
Anaemiaa 222 (29.6%) 127 (19.3%)
Microcytic anaemia
(MCV< 80 fl)
9 (4.1%) 13 (10.2%)
Normocytic anaemia
(MCV 80–100 fl)
190 (85.6%) 104 (81.9%)
Macrocytic anaemia
(MCV> 100 fl)
23 (10.4%) 10 (7.9%)
RBC (×109/l) 4.3 (3.9–4.6) 4.5 (4.2–4.8)
Platelets (×109/l) 249 (209–297) NA
WBC (×109/l) 6.4 (5.4–7.6) 6.1 (5.2–7.3)
Telomere length (bp) 2,889 (2,427–3,589) 4,163 (3,885–4,495)
Men 3,005 (2,517–3,832) 4,277 (3,972–4,684)
Women 2,797 (2,356–3,418) 4,113 (3,849–4,425)
Other clinical characteristics
MMSE (points) 28 (25–29) 26 (20–29)
Ferritin (μg/l) 59 (28–121) NA
Vitamin B12 (pg/ml) 313 (230–437) NA
Red cell folate (μg/l) 383 (271–565) NA
Creatinine (μmol/l) 99 (86–119) NA
C-reactive protein (mg/l) 2.6 (1.2–5.9) NA
Comorbidity
Stroke 100 (13.4%) 20 (3.0%)
Myocardial infarction 110 (14.7%) 49 (7.4%)
Dementia 52 (7.0%) 50 (7.6%)
Diabetes mellitus 101 (13.5%) 82 (12.5%)
Malignancy 184 (24.6%) 106 (16.1%)
Categorical data are presented as N (%). Continuous data are presented as
median (interquartile range).
MCV, mean cell volume; RBC, red blood cell count; WBC, white blood cell
count; MMSE, Mini Mental State Examination.
aHaemoglobin <12 g/dl for women and <13 g/dl for men.
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Figures 1A and B are scatter plots with superimposed
regression lines of haemoglobin levels (y-axis) against telo-
mere length (x-axis) for men and women separately. There
was no relation between telomere length and haemoglobin
levels in either men or women (linear regression analyses,
P> 0.40). No associations were found in both populations
when we adjusted the regression analyses in the total study
populations for gender (Hb 0.021 g/dl (P = 0.69) per
1,000 bp increase in telomere length in the Newcastle
85-plus Study and Hb 0.055 g/dl (P = 0.40) in the Leiden
85-plus Study). Similar results were found when we also
adjusted for stroke, myocardial infarction, dementia, dia-
betes mellitus and malignancy (data not shown).
In addition, no association between telomere length and
haemoglobin was found when we performed one
regression analysis combining both study populations (Hb
0.034 g/dl (P = 0.40) per 1,000 bp increase in telomere
length, adjusted for gender and study population).
No differences in median telomere length were observed
between participants with anaemia and participants without
anaemia (Table 2, Newcastle 85-plus Study: 2,846 bp (IQR
2,433–3,630) versus 2,920 bp (IQR 2,425–3,570), P = 0.63;
Leiden 85-plus Study: 4,136 bp (IQR 3,879–4,428) versus
4,167 bp (IQR 3,893–4,501), P = 0.41). Similar results were
found when we stratified on gender or when we restricted
the analysis in the Leiden 85-plus Study to participants
aged 85–89 years (n= 384).
Appendices 1 and 2 available as Supplementary data in
Age and Ageing online show the haematological character-
istics depending on quintiles of telomere length for men
and women, respectively. In both men and women, telo-
mere length was not associated with any of the haematolo-
gical parameters, either in the Newcastle 85-plus Study or
in the Leiden 85-plus Study. We did find a P value <0.05
for the association between telomere length and platelets
for men in the Newcastle 85-plus Study, but this may be
considered a chance finding as there was not a clear dose-
dependent relation between telomere length and platelet
count.
In the Newcastle 85-plus Study, no differences in telo-
mere length were found between participants with RBC,
platelets and WBC in the lowest gender-dependent quartile
(n = 30) and participants with RBC, platelets and WBC in
the highest gender-dependent quartile (n = 14) (2,771 (IQR
2,127–3,099) versus 3,024 (2,654–3,724), P= 0.18). In
addition, we did not find any differences in median telo-
mere length between participants with unexplained anaemia
(n = 79) and participants with explained anaemia (n = 143):
2,809 bp (IQR 2,278–3,491) versus 2,880 bp (IQR 2,494–
3,759), P = 0.40. Furthermore, no differences in median tel-
omere length were found between participants with unex-
plained anaemia (n = 79) and participants without anaemia
and normal ferritin, vitamin B12, red cell folate, CRP and
creatinine concentrations (n= 318) (2,809 bp (IQR 2,278–
3,491) versus 2,932 bp (2,405–3,574) respectively, P =
0.35).
Discussion
We examined the relation between telomere length and
anaemia, with the prior expectation of adding anaemia to
the list of conditions for which telomere reduction is a risk
factor. A surprise negative finding in one population led us
to verify this finding in a second independent cohort. In
both cohorts of older individuals, we found no association
Figure 1. Scatter plots with superimposed regression lines of haemoglobin levels (y-axis) against telomere length (x-axis) in the
Newcastle 85-plus Study (A, n= 749) and Leiden 85-plus Study (B, n= 658). Legend: grey circle, men; black circle, women. No
significant associations were observed (all P> 0.40).
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between telomere length and haemoglobin concentration or
any other haematological parameter.
The lack of association between telomere length and
anaemia was unexpected. First, telomere length has been
correlated with many other major age-related diseases
[1–5]. Second, myelodysplastic syndromes or other types
of bone marrow failure are thought to explain the
increased frequency of (unexplained) anaemia in older
individuals [7, 15, 16]. Adult haematopoietic stem cells
show a severe loss of telomeric DNA compared with
cells from fetal liver or umbilical cord blood [17] and
aged mice have a decreased capacity to replace blood
cells during haematopoietic stress compared with
younger mice [15, 18], indicating a loss of replicative
potential for bone marrow stem cells with age [17, 19]
and a possible incapacity to react to the physiologic
demand for blood cell replenishment with age [15, 16,
18]. Since the results of earlier studies indicate that
patients with myelodysplastic syndromes or other types
of bone marrow failure syndromes have shortened telo-
meres [20–22], shorter telomere length has been associ-
ated with an increased risk of anaemia in chronic heart
failure patients [23] and shorter telomere length was an
independent predictor of lower red blood cell counts in
a study of middle-aged subjects (aged 35–55 years) [24],
we hypothesised that telomere length is a marker of hae-
matopoietic ageing and bone marrow failure, and as a
result would be associated with anaemia in older individ-
uals in the general population. The results of this study,
however, do not support this hypothesis.
One possible explanation for the lack of association
between telomere length and anaemia in our study may
be that telomere length in WBC in old age is very
unstable and does not have enough predictive power for
age-related morbidity and mortality at ages over 85 years
[25]. This explanation, however, seems unlikely, because
we recently found a strong and significant relation
between telomere length and left ventricular function in
the pilot study of the Newcastle 85-plus Study (n = 89,
aged 85 years) [3]. Another explanation for the lack of
association between telomere length and anaemia may be
that, despite the results from earlier studies suggesting
otherwise [23, 24], there, in fact, is no association
between telomere length and bone marrow failure, or
bone marrow failure and anaemia, in the general popu-
lation of older individuals. This explanation is supported
by the results from a study by Mollica et al. [26] in
which no correlation was found between telomere length
and blood counts in a population-based sample of 717
women aged 38–100 years (median 72 years).
Our findings do not preclude that short telomeres may
drive aplastic syndromes. However, the repetitive negative
findings presented here suggest that in the population at
large, a myelodysplastic syndrome per se is an unlikely
explanation for the presence of anaemia in older people.
Similar discrepancies between studies in selected popu-
lations and population-based studies have been reported
previously. For instance, Cherkas et al. [27] found an associ-
ation between socio-economic status and telomere length in
female twins aged 18–75 years, but no such association was
found by Adams et al. [28] in an unselected cohort of
50-year-olds.
We observed a large difference in median telomere
length between the two cohorts. Participants in the
Newcastle 85-plus Study had shorter telomeres than partici-
pants in the Leiden 85-plus Study. This difference could
not be explained by differences in laboratory techniques,
since both collections of samples were measured using the
same equipment and the same reagents and assays, and
subsequent real-time PCR data analysis was performed by
the same person (C.M.-R.). The fact that DNA samples
were derived from WBC in the Newcastle 85-plus Study
and from PBMC in the Leiden 85-plus Study is unlikely to
explain this difference in telomere length. Granulocytes
tend to have longer telomeres than lymphocytes [29, 30].
The difference in telomere length between these two cell
populations increases with age [29, 30], which would have
led us to expect longer median telomere length in the
cohort from Newcastle. The difference in telomere length
between the populations is as yet unexplained; possible
factors include differences in disease incidence, dietary pat-
terns or socio-economical status. In addition, in both study
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 2. Telomere length in base pairs for participants with and without anaemia
Anaemiaa No anaemia P
n Median (IQR) n Median (IQR)
Newcastle 85-plus Study
Total population 222 2,846 (2,433–3,630) 527 2,920 (2,425–3,570) 0.63
Men 98 2,994 (2,518–3,789) 197 3,025 (2,513–3,899) 0.71
Women 124 2,782 (2,341–3,536) 330 2,816 (2,362–3,399) 0.54
Leiden 85-plus Study
Total population 127 4,136 (3,879–4,428) 531 4,167 (3,893–4,501) 0.41
Men 47 4,194 (3,955–4,585) 129 4,329 (3,982–4,701) 0.26
Women 80 4,085 (3,877–4,360) 402 4,121 (3,844–4,443) 0.51
Data are presented as median (interquartile range). P values were obtained by Mann–Whitney U tests.aHaemoglobin <12 g/dl for women and <13 g/dl for men.
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populations we found shorter telomeres in women com-
pared with men, the opposite of what is generally expected.
This finding illustrates the rather strange telomere biology
in the older populations, and may indicate that telomere
length cannot be used unconditionally as a biomarker of
the human aging process [25].
A limitation of the present study is its cross-sectional
design, which restricts our capacity to draw conclusions
about causal relations. Given that a proportion of older
persons with unexplained anaemia may be due to myelody-
plastic syndrome [7, 15, 16] and that earlier studies have
linked myelodysplasia with shorter telomeres [20–22], it is a
limitation of our study that the information on the causes
of anaemia was only present in the Newcastle 85-plus
Study. Another limitation is that in neither of the studies
bone marrow biopsies were available to confirm the diag-
nosis of myelodysplasia or bone marrow failure [15].
A strength of our analysis is that we made use of data
from two large studies of individuals aged 85 years and
over, giving us a unique opportunity to cross-validate our
negative findings, especially since in both studies telomere
length was measured in the same laboratory using the same
validated technique [14, 25]. Another strong point of the
present study is the population-based nature of both
cohorts, allowing us to generalise our results to the popu-
lation of older people at large.
In conclusion, in contrast to other age-related diseases,
telomere length is not associated with anaemia or any other
haematological parameter in older individuals in the general
population, despite the plausible biological mechanism
underlying this association. To further investigate this intri-
guing matter, studies incorporating bone marrow biopsies
will be needed.
Key points
• Reduced telomere length in blood cells has been associ-
ated with increased risk of multiple age-related diseases.
• Telomere length is not associated with anaemia or any
other haematological parameter in old age.
• To further investigate this matter, studies incorporating
bone marrow biopsies will be needed.
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